Furthermore, there was a positive correlation between the level of HULC, ESM-1, MVD (CD34) and VEGF in glioma patient tissue, suggesting that there was a potential relationship between HULC, ESM-1 and angiogenesis in the tumor progression. Here, CD34 is linked to central nervous system cancer.